United States Protein Purification and Isolation Market

United States Protein Purification and Isolation Market Size

As per the survey report on United States protein purification and isolation market, the market is expected to foresee a CAGR value of 10.3% during 2026-2036, and further generate a market size of USD 10.2 billion by the end of 2036. In 2025, the market size was value at USD 3.7 billion revenue.

• The United States protein purification and isolation market’s growth is driven by rising demand for biopharmaceuticals.
• KDMI analyst’s growth analysis foresees scalability challenges as restraint for United States protein purification and isolation market.
• In the United States protein purification and isolation market, application segment is playing significant role.

United States Protein Purification and Isolation Market Analysis

Protein purification and isolation is a multi-step laboratory process used to separate a specific, target protein from a complex mixture, such as cell lyStates, tissues, or organisms. It is essential for determining a protein’s structure, function, and interactions for research or industrial applications. The United States market protein purification and isolation market growth is driven by increasing demand for biopharmaceuticals, advancements in protein-based R&D, and increasing adoption of high-value biologics. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), United States biopharmaceutical industry spent approximately USD 96 billion in research and development, as the industry is world leader. The United States biopharmaceutical industry attracts more new foreign direct investments than any other industry, reaching USD 503.4 billion in 2023 . Therefore, these expansion of biopharmaceuticals supports R&D for protein’s purification and isolation to ensure its purity and reliability.

United States Protein Purification and Isolation Market Growth Drivers and Restraints

Growth Drivers

• Rising demand for biopharmaceuticals and biologics – The accelerating demand for biopharmaceuticals and biologics in the United States is a key driver of the protein purification and isolation market, as these therapies such as monoclonal antibodies, recombinant proteins, vaccines, and cell-based treatment requires extremely high levels of purity, safety, and efficacy. According to the 2022 U.S Generic and Biosimilar Medicines Savings Report, the drugs generated revenue of USD 373 billion for America’s patients and healthcare system in 2021 . As of 2024, 34 new chemical drugs and 2 new vaccines were approved by the US Food and Drug Administration (FDA). Moreover, the growing prevalence of chronic diseases, including cancer and autoimmune disorders has significantly expanded the biologics adoption, thereby increasing reliance on multi-step purification and filtration processes to meet stringent regulatory standards.
• Expanding role in diagnostics and personalized medicine – Protein purification is becoming increasingly important in diagnostics and personalized medicine in the United States. During 2019-2020, the health spending increased by 10.4% and between 2022-2023, health spending grew by 7.5%, faster than 2021-2022 . According to PMC, FDA has approved 16 new personalized medicines for rare disease treatments in 2023, accounting for an increase of 6 from 2022 . Therefore, the growing burden of chronic diseases has accelerated demand for early and precise diagnostic tools further supporting the need for efficient protein isolation methods.  Additionally, expansion of point-of-care testing and decentralized healthcare is driving adoption of rapid, miniaturized purification technologies, which highlights the importance of protein purification and isolation.

Restraints

• Scalability challenges – The key restraint is the scaling protein purification processes from laboratory research to commercial manufacturing poses a significant challenge, as maintaining purity, safety, and efficiency requires high upfront costs. It also requires additional optimization, investment in specialized large-scale equipment, and process redesign, thereby limiting adoption in small-scale manufacturing units.
• Technical complexity – Another significant barrier for market growth is the purification processes involving complex, multi-step workflows. These multi-step protein purification demands technical expertise to operate, optimize, and troubleshoot effectively, thereby slowing market expansion across the US.

United States Protein Purification and Isolation Market Segmentation

Our experts at KD Market Insights have segmented the United States protein purification and isolation market research report as:

Analyst’s Observation on United States Protein Purification and Isolation Market Recent Developments

Over the years, the experts at KD Market Insights have been observing the recent developments associated with United States protein purification and isolation market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.

FUJIFILM Corporation has recently announced the development of an innovative screening methodology for cyclic peptides exhibiting high affinity toward membrane proteins. This new technology enables Fujifilm to offer cyclic peptide discovery services targeting challenging membrane proteins, including multi-pass transmembrane proteins, which represent complex drug targets.

Merck, a leading science and technology company, has announced the acquisition of the chromatography business of JSR Life Sciences. The acquisition adds Amsphere Protein A resins and advanced Protein A chromatography capabilities to Merck’s downstream processing portfolio, enabling efficient, scalable purification of monoclonal antibodies.

United States Protein Purification and Isolation Market Competitive Landscape

Some of the significant participants who top the United States protein purification and isolation market growth:

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• QIAGEN
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Cube Biotech GmbH
• Promega Corporation
• Norgen Biotek Corp.
• Takara Bio. Inc.
• Danaher